CRL News

Charles River Laboratories Announces Chief Financial Officer Transition

CRL

(NYSE:CRL) WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Chief Financial Officer Transition

September 16, 2025Management
Read more →

Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership

CRL

(NYSE:CRL) CHICAGO--(BUSINESS WIRE)--Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership

September 16, 2025Expansion
Read more →

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

CRL

(NYSE:CRL) WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #CDMO--Charles River collaborates to enhance oncology manufacturing portfolio by advancing development of cell and gene therapies to treat cancer.

September 11, 2025Collaboration
Read more →

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

CRL

(NYSE:CRL) WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

CRL

(NYSE:CRL) WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Integration of Akadeum’s GMP-grade Human T Cell Leukopak Isolation Kit into Charles River’s Cell Therapy Flex Program announced today

September 3, 2025Partnership
Read more →

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

CRL

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River joins EASYGEN to provide 3D screening expertise, supporting the development of a bedside CAR-T manufacturing platform .

Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing

CRL

CHICAGO--(BUSINESS WIRE)--Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing

August 13, 2025Financing
Read more →

Cresco Labs Announces Commitments to Refinance its Senior Secured Credit Facility

CRL

CHICAGO--(BUSINESS WIRE)--Cresco Labs Announces Commitments to Refinance its Senior Secured Credit Facility

August 6, 2025Finance
Read more →

Charles River Laboratories Announces Second-Quarter 2025 Results

CRL

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories Announces Second-Quarter 2025 Results

August 6, 2025Earnings
Read more →

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

CRL

WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River today announced a recycling program, developed in partnership with TerraCycle to give new life to single-use plastic cartridges.

Circle Stock Has Popped 271% Since NYSE Debut, Now A KPMG Consultant Says This Is The Next Big Thing After Stablecoins

CRL

Tarun Anand, KPMG’s Blockchain and Digital Asset Consultant, said stablecoins, real-world asset tokenization and decentralized physical infrastructure networks will be the key cryptocurrency narratives to watch out for in the next few years.

June 10, 2025
Read more →

Charles River Labs And CHDI Foundation Announce Extension Of Ongoing Drug Discovery Partnership Into Foreseeable Future

CRL

May 28, 2025
Read more →

This Waste Management Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

CRL

May 23, 2025
Read more →

Redburn Atlantic Upgrades Charles River to Buy, Lowers Price Target to $182

CRL

May 23, 2025
Read more →

What 10 Analyst Ratings Have To Say About Charles River

CRL

May 8, 2025
Read more →

Barclays Maintains Equal-Weight on Charles River, Raises Price Target to $155

CRL

May 8, 2025
Read more →

Baird Maintains Neutral on Charles River, Raises Price Target to $140

CRL

May 8, 2025
Read more →

Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs of Demand Stabilization

CRL

Charles River shares rise after Q1 adjusted EPS and revenue top estimates; company raises 2025 outlook and adds four directors to its board.

May 7, 2025
Read more →

Charles River Laboratories Announces Board Changes and Strategic Review

CRL

May 7, 2025
Read more →

Charles River Raises FY2025 GAAP EPS Guidance from $4.30-$4.80 to $4.35-$4.85 vs $5.68 Est

CRL

May 7, 2025
Read more →

Charles River Raises FY2025 Adj EPS Guidance from $9.10-$9.60 to $9.30-$9.80 vs $9.33 Est; Raises FY2025 Sales Guidance from $3.77B-$3.87B to $3.83B-$3.91B vs $3.82B Est

CRL

May 7, 2025
Read more →

Charles River Q1 Adj. EPS $2.34 Beats $2.08 Estimate, Sales $984.17M Beat $941.97M Estimate

CRL

May 7, 2025
Read more →

9 Health Care Stocks With Whale Alerts In Today's Session

CRL

April 22, 2025
Read more →

Wall Street Rebounds, JPMorgan Jumps On Strong Q1 Earnings: What's Driving Markets Friday?

CRL

Wall Street bounced back from early losses, driven by upbeat bank earnings and cooler inflation data, while shrugging off trade war concerns.

April 11, 2025
Read more →

'FDA Announces Plan to Phase Out Animal Testing Requirement For Monoclonal Antibodies And Other Drugs' - FDA

CRL

April 10, 2025
Read more →

Barclays Maintains Equal-Weight on Charles River, Lowers Price Target to $145

CRL

April 10, 2025
Read more →

Charles River Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)

CRL

April 9, 2025
Read more →

Mizuho Maintains Neutral on Charles River, Lowers Price Target to $155

CRL

April 9, 2025
Read more →

Demystifying Charles River: Insights From 10 Analyst Reviews

CRL

March 21, 2025
Read more →

This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

CRL

March 21, 2025
Read more →

Goldman Sachs Downgrades Charles River to Neutral, Lowers Price Target to $170

CRL

March 21, 2025
Read more →

Citigroup Upgrades Charles River to Neutral, Raises Price Target to $175

CRL

March 4, 2025
Read more →

JP Morgan Maintains Neutral on Charles River, Lowers Price Target to $165

CRL

February 20, 2025
Read more →

Baird Maintains Neutral on Charles River, Lowers Price Target to $173

CRL

February 20, 2025
Read more →

Barclays Maintains Equal-Weight on Charles River, Lowers Price Target to $160

CRL

February 20, 2025
Read more →

Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance

CRL

Charles River's Q4 revenue topped estimates despite a 1.1% decline. The company forecasts a revenue drop in 2025, with biotech demand expected to stabilize.

February 19, 2025
Read more →

Charles River Sees FY25 Adjusted EPS Of $9.10-$9.60 Vs. $9.60 Estimate

CRL

February 19, 2025
Read more →

Charles River Plans To Repurchase Approximately $350M In Common Stock In 2025

CRL

February 19, 2025
Read more →

Charles River Q4 2024 Adj. EPS $2.66 Beats $2.53 Estimate, Sales $1.003B Beat $983.627M Estimate

CRL

February 19, 2025
Read more →

Analyst Expectations For Charles River's Future

CRL

February 18, 2025
Read more →

Barclays Maintains Equal-Weight on Charles River, Lowers Price Target to $166

CRL

February 18, 2025
Read more →

William Blair Reiterates Outperform on Charles Riverto Outperform

CRL

January 14, 2025
Read more →

Charles River Laboratories Sees Prelim. FY25 Revenue To Decline Organically In Similar Range As Estimated In 2024

CRL

January 14, 2025
Read more →

Charles River Q3 Earnings: CEO Notes Improved Biotech Funding And Stabilizing Demand - Here's Why

CRL

Charles River Labs Q3 revenue of $1.01 billion surpassed expectations; however, revenue declined 1.6% YoY, and operating margin dropped to 11.6% amid restructuring costs.

November 6, 2024
Read more →

Charles River Laboratories Raises FY24 Outlook: Sees Adjusted EPS Of $10.10–$10.30 Vs. $10 Estimate (Prior View: $9.90–$10.20)

CRL

November 6, 2024
Read more →

Charles River Q3 2024 Adj. EPS $2.59 Beats $2.43 Estimate, Sales $1.009B Beat $976.015M Estimate

CRL

November 6, 2024
Read more →

Charles River: Q1 Earnings Insights

CRL

Charles River (NYSE:CRL) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

May 4, 2022
Read more →

Charles River Maintains FY22 Adj EPS And Sales Guidance

CRL

May 4, 2022
Read more →

Charles River Q1 EPS $2.75 Beats $2.71 Estimate, Sales $913.90M Beat $910.10M Estimate

CRL

May 4, 2022
Read more →

Preview: Charles River's Earnings

CRL

Charles River (NYSE:CRL) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Charles River will report an earnings per share (EPS) of $2.71.

May 3, 2022
Read more →